Hope Happens aims to improve the lives of people with neurodegenerative disorders by promoting collaborative, translational research with the potential to fast-track new cures. The organization’s focus is on a small family of neurological disorders, including ALS, Alzheimer’s disease, Cerebral Palsy, Epilepsy, Multiple Sclerosis, Parkinson’s disease, traumatic spinal cord and brain injury and stroke.
“Our underlying belief is that these diseases all may have one common mechanism, and if we can unlock that one mechanism, then we may be able to help cure all the diseases,” Kindle said. “Discoveries about one disorder can lead to treatments and cures for others.”
In November of 2004, Hope Happens partnered with Washington University to launch the Hope Center for Neurological Disorders at Washington University in St. Louis, a research center dedicated to speeding the process of translating basic scientific discoveries into therapies and cures. Both partners are convinced that discoveries in one disorder will lead to progress with others. The Hope Center is leading the way in a new model by sharing not only information amongst those study separate neurological disorders, but also a core facility.
“I think of it similar to working on a business problem,” Kindle said. “You get everyone – those from logistics to those from sales – and work together on the problem to consider all sides. There are a lot of similarities in those two processes.”
In order for Hope Happens to focus on its mission and providing funding to The Hope Center, the organization relies on ARCHS’ Leveraged Resources Management (LRM) for its financial expertise. By having LRM handle its accounting, Hope Happens can focus on improving the lives of people with those neurodegenerative disorders.